Alvotech Ordinary Shares (ALVO)
Stock · NASDAQ · Health Care
$4.95as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$3.29
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $1.18B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
Alvotech Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ALVOAlvotech Ordinary Shares$4.95▲ 1.43%Market cap $1.18BP/E —
- VORVor Biopharma Inc. Common Stock$22.66▼ 3.70%Market cap $1.16BP/E —$6.5$49.95
- IMTXImmatics N.V. Ordinary Shares$9.45▲ 0.91%Market cap $1.21BP/E —$5.05$12.41
- INBXInhibrx Biosciences Inc. Common Stock$123.93▼ 0.00%Market cap $1.21BP/E —$26.19$155.29
- MGTXMeiraGTx Holdings plc Ordinary Shares$13.8▼ 2.40%Market cap $1.10BP/E 15.54$6.62$15.35
- GLUEMonte Rosa Therapeutics Inc. Common Stock$13.37▼ 6.63%Market cap $1.30BP/E —$4.6$25.77
- SANASana Biotechnology Inc. Common Stock$3.93▼ 3.91%Market cap $884.97MP/E —$2.61$6.55
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ALVO Alvotech Ordinary Shares | $1.18B | — | $4.95 | ▲ 1.43% | |
| VOR Vor Biopharma Inc. Common Stock | $1.16B | — | $22.66 | ▼ 3.70% | $6.5$49.95 |
| IMTX Immatics N.V. Ordinary Shares | $1.21B | — | $9.45 | ▲ 0.91% | $5.05$12.41 |
| INBX Inhibrx Biosciences Inc. Common Stock | $1.21B | — | $123.93 | ▼ 0.00% | $26.19$155.29 |
| MGTX MeiraGTx Holdings plc Ordinary Shares | $1.10B | 15.54 | $13.8 | ▼ 2.40% | $6.62$15.35 |
| GLUE Monte Rosa Therapeutics Inc. Common Stock | $1.30B | — | $13.37 | ▼ 6.63% | $4.6$25.77 |
| SANA Sana Biotechnology Inc. Common Stock | $884.97M | — | $3.93 | ▼ 3.91% | $2.61$6.55 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Alvotech 2026 Q2 - Results - Earnings Call PresentationSeekingAlpha · 8/21/2026
- Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming CatalystsSeekingAlpha · 8/20/2026
- Alvotech (ALVO) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/20/2026
- Alvotech Q2 2026 Earnings Call TranscriptBenzinga · 8/20/2026
- Alvotech Q2 EPS $(0.17) Misses $(0.04) Estimate, Sales $106.000M Miss $111.010M EstimateBenzinga · 8/19/2026
- Alvotech Affirms FY2026 Sales Guidance of $650.000M-$700.000M vs $644.838M EstBenzinga · 8/19/2026
- Evercore ISI Group Initiates Coverage On Alvotech with Outperform RatingBenzinga · 8/14/2026
- X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue EstimatesYahoo · 8/6/2026
See the full, filterable feed with live charts on the MarketWall dashboard.